CVRX
NASDAQCVRx
$2.39
-3.55 (-59.76%)
Institutional
63.5%
Insider
9.55%
Retail/Other
26.9%
Shares Outstanding
26.5M
Top Institutional Holders
As of Aug 2026| Holder | Shares | % | Change |
|---|---|---|---|
| Johnson & Johnson | 4.0M | 15.2% | - |
| NEA Management Company, LLC | 2.0M | 7.6% | - |
| Vanguard Group Inc | 1.1M | 4.2% | +0.0M |
| BlackRock Inc | 1.0M | 3.9% | -0.0M |
| GSK PLC | 1.0M | 3.8% | - |
| Vanguard Capital Management, LLC | 911K | 3.4% | +0.9M |
| Royal Bank of Canada | 707K | 2.7% | +0.7M |
| Balyasny Asset Management LLC | 631K | 2.4% | -0.2M |
| Silvercrest Asset Management Group LLC | 572K | 2.2% | -0.1M |
| Parkman Healthcare Partners LLC | 430K | 1.6% | +0.0M |
Insider Transactions
Last 24 months (15 insiders)
JOHNSON & JOHNSON / Johnson & Johnson Innovation - JJDC, Inc.
10% Owner/ 10% Owner
4,040,861 shares
Sales (8)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 6,337 | $10.03 | $63,560 | 2025-11-26 | 4,040,861 |
| 6,337 | $10.03 | $63,560 | 2025-11-26 | 4,024,861 |
| 16,000 | $10.03 | $160,480 | 2025-11-25 | 4,031,198 |
| 2,200 | $10.06 | $22,132 | 2025-11-24 | 4,047,198 |
| 500 | $10.00 | $5,000 | 2025-11-21 | 4,049,398 |
| 1,000 | $10.00 | $10,000 | 2025-11-12 | 4,049,898 |
| 200 | $10.00 | $2,000 | 2025-11-07 | 4,050,898 |
| 52,332 | $10.21 | $534,310 | 2025-11-06 | 4,051,098 |
Kevin Hykes
PRES & CEO
284,237 shares
Sales (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 7,763 | $7.90 | $61,349 | 2026-03-02 | 284,237 |
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 159,000 | - | $1,297,440* | 2026-02-27 | 292,000 |
Jared Oasheim
CHIEF FINANCIAL OFFICER
96,703 shares
Sales (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 1,744 | $7.90 | $13,781 | 2026-03-02 | 96,703 |
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 61,000 | - | $497,760* | 2026-02-27 | 98,447 |
Robert Allen John
Chief Revenue Officer
86,036 shares
Sales (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 3,964 | $7.90 | $31,326 | 2026-03-02 | 86,036 |
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 35,000 | - | $285,600* | 2026-02-27 | 90,000 |
Philip B. Adamson
Chief Medical Officer
61,578 shares
Sales (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 1,262 | $7.90 | $9,973 | 2026-03-02 | 61,578 |
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 41,000 | - | - | 2026-02-27 | 62,840 |
Paul Verrastro
CHIEF MKTG & STRAT OFFICER
60,551 shares
Sales (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 1,284 | $7.90 | $10,146 | 2026-03-02 | 60,551 |
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 45,000 | - | $367,200* | 2026-02-27 | 61,835 |
Joseph P Slattery
Director
39,365 shares
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 8,720 | - | $47,350* | 2026-06-01 | 39,365 |
Gregory Morrison
CHIEF HUMAN RESOURCES OFFICER
34,000 shares
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 34,000 | - | $279,480* | 2026-03-02 | 34,000 |
Brent Binkowski
CHIEF OPERATING OFFICER
31,600 shares
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 15,000 | - | $122,400* | 2026-02-27 | 31,600 |
DALE MICHAEL D
Director
29,005 shares
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 29,005 | - | $157,497* | 2026-06-01 | 29,005 |
Mudit K. Jain
Director
14,370 shares
Buys (2)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 46,800 | $6.36 | $297,592 | 2026-02-20 | 980,183 |
| 600 | $4.64 | $2,785 | 2026-02-18 | 5,650 |
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 8,720 | - | $47,350* | 2026-06-01 | 14,370 |
Kevin J. Ballinger
Director
8,720 shares
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 8,720 | - | $47,350* | 2026-06-01 | 8,720 |
Martha Shadan
Director
8,720 shares
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 8,720 | - | $47,350* | 2026-06-01 | 8,720 |
Mitch C. Hill,
Director
8,720 shares
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 8,720 | - | $47,350* | 2026-06-01 | 8,720 |
Kirk G. Nielsen
Director
8,720 shares
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 8,720 | - | $47,350* | 2026-06-01 | 8,720 |
Insider Activity Summary
Last 24 monthsTotal Bought
47,400 shares
$300,377
Total Sold
100,923 shares
$987,617
Net Shares
-53,523
Net Value
$-687,240
Activity by Insider
| Name | Bought | Sold | Net Shares | Net Value |
|---|---|---|---|---|
|
JOHNSON & JOHNSON / Johnson & Johnson Innovation - JJDC, Inc.
10% Owner/ 10% Owner
|
- | -84,906 | -84,906 | $-861,042 |
|
Mudit K. Jain
Director
|
+47,400 | - | +47,400 | $+300,377 |
|
Kevin Hykes
PRES & CEO
|
- | -7,763 | -7,763 | $-61,349 |
|
Robert Allen John
Chief Revenue Officer
|
- | -3,964 | -3,964 | $-31,326 |
|
Jared Oasheim
CHIEF FINANCIAL OFFICER
|
- | -1,744 | -1,744 | $-13,781 |
|
Paul Verrastro
CHIEF MKTG & STRAT OFFICER
|
- | -1,284 | -1,284 | $-10,146 |
|
Philip B. Adamson
Chief Medical Officer
|
- | -1,262 | -1,262 | $-9,973 |
Net insider selling: 53,523 shares ($687,240) in last 12 months
Congressional Trading
STOCK Act DisclosuresNo congressional trading data available for this ticker.
Congressional trading data is sourced from STOCK Act disclosures and may not be available for all tickers.
Based on public disclosures. Reporting errors by representatives are common. Disclosure deadlines are 45 days after transaction.